{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:52:20Z","timestamp":1794552740090,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Donor-derived cell-free DNA (dd-cfDNA) is an emerging biomarker of kidney allograft injury, mainly investigated in the context of rejection. However, the dd-cfDNA dynamics in other graft pathologies merit further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>In this single-center observational study, we prospectively collected dd-cfDNA at indication biopsies. To evaluate the association between dd-cfDNA and different histological patterns, we correlated absolute and relative dd-cfDNA (thresholds of 50 copies\/mL and 0.5%, respectively) with the Banff 2022 lesion scores and the assigned diagnoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>We examined 151 dd-cfDNA paired biopsies in 131 kidney transplant recipients and found significantly higher absolute dd-cfDNA levels in antibody-mediated rejection (n, median, IQR: 45, 63 copies\/mL, 42\u201389), microvascular inflammation (MVI) without donor-specific antibodies or C4d-deposition (6, 102 copies\/mL, 61\u2013134), mixed rejection (8, 140 copies\/mL, 77\u2013171), and BK virus\u2013associated nephropathy (6, 213 copies\/mL, 83\u2013298) compared with glomerulonephritis (20, 12 copies\/mL, 8\u201318), calcineurin toxicity (19, 10 copies\/mL, 7\u201316), interstitial fibrosis\/tubular atrophy (12, 10 copies\/mL, 9\u201316) and normal histology (6, 9 copies\/mL, 7\u201316). In the multivariable analysis, absolute and relative dd-cfDNA correlated with the peritubular capillaritis (ptc), glomerulitis (g), and tubulitis (t) scores. In the receiver operating characteristic analysis, absolute dd-cfDNA showed best discrimination for MVI of any cause (area under the curve [AUC] 0.88, sensitivity 0.71, specificity 0.86, positive predictive value [PPV] 0.76, negative predictive value [NPV] 0.82), followed by antibody-mediated rejection including mixed rejection (AUC 0.85, sensitivity 0.72, specificity 0.83, PPV 0.69, NPV 0.84), and overall rejection (AUC 0.83, sensitivity 0.66, specificity 0.85, PPV 0.76, NPV 0.77). T cell\u2013mediated rejection was only detectable by dd-cfDNA when associated with vascular lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Altogether, we conclude that dd-cfDNA-release is not limited to rejection-related injury phenotypes and is mainly driven by MVI in kidney allografts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001794","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T22:00:12Z","timestamp":1744322412000},"page":"e1794","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Association of Blood Donor-derived Cell-free DNA Levels With Banff Scores and Histopathological Lesions in Kidney Allograft Biopsies: Results From an Observational Study"],"prefix":"10.1097","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9227-8017","authenticated-orcid":false,"given":"Aylin","family":"Akifova","sequence":"first","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-5942","authenticated-orcid":false,"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0286-1491","authenticated-orcid":false,"given":"Mira","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[{"name":"Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Buettner-Herold","sequence":"additional","affiliation":[{"name":"Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oellerich","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beck","sequence":"additional","affiliation":[{"name":"Chronix Biomedical GmbH, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bornemann-Kolatzki","sequence":"additional","affiliation":[{"name":"Chronix Biomedical GmbH, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Sch\u00fctz","sequence":"additional","affiliation":[{"name":"Chronix Biomedical GmbH, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Bachmann","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Halleck","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva V.","family":"Schrezenmeier","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Seelow","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Zukunft","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hammett","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Pohl","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Mord\u00e0","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."},{"name":"Nephrology Unit, University Hospital of Parma, Parma, Italy."},{"name":"Department of Medicine and Surgery, University of Parma, Parma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kowald","sequence":"additional","affiliation":[{"name":"Medical Department III, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Lachmann","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Histocompatibility and Immunogenetics Laboratory, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Stauch","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Histocompatibility and Immunogenetics Laboratory, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8660-0722","authenticated-orcid":false,"given":"Bilgin","family":"Osmanodja","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"R1-20250411","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation.","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"R2-20250411","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1681\/ASN.2017010004","article-title":"Precision transplant medicine: biomarkers to the rescue.","volume":"29","author":"Naesens","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R3-20250411","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/TP.0000000000001321","article-title":"Establishing biomarkers in transplant medicine: a critical review of current approaches.","volume":"100","author":"Anglicheau","year":"2016","journal-title":"Transplantation"},{"key":"R4-20250411","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/TP.0000000000005122","article-title":"Biomarkers in kidney transplantation: A rapidly evolving landscape.","volume":"109","author":"Gupta","year":"2024","journal-title":"Transplantation"},{"key":"R5-20250411","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.ajkd.2024.07.018","article-title":"Biomarkers of rejection in kidney transplantation.","volume":"85","author":"Westphal","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"R6-20250411","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/TP.0000000000002482","article-title":"Donor-specific cell-free DNA as a biomarker in solid organ transplantation: a systematic review.","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"R7-20250411","doi-asserted-by":"crossref","first-page":"1031894","DOI":"10.3389\/fgene.2022.1031894","article-title":"Donor-derived cell-free DNA as a diagnostic TOOL in transplantation.","volume":"13","author":"Oellerich","year":"2022","journal-title":"Front Genet"},{"key":"R8-20250411","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","article-title":"Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R9-20250411","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1373\/clinchem.2013.210328","article-title":"Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury.","volume":"59","author":"Beck","year":"2013","journal-title":"Clin Chem"},{"key":"R10-20250411","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study.","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant"},{"key":"R11-20250411","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR.","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"R12-20250411","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients.","volume":"18","author":"Grskovic","year":"2016","journal-title":"J Mol Diagn"},{"key":"R13-20250411","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts.","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R14-20250411","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","article-title":"Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients.","volume":"4","author":"Jordan","year":"2018","journal-title":"Transplant Direct"},{"key":"R15-20250411","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/tri.13753","article-title":"Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis.","volume":"33","author":"Wijtvliet","year":"2020","journal-title":"Transpl Int"},{"key":"R16-20250411","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2215\/CJN.05530421","article-title":"Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients.","volume":"16","author":"Park","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-20250411","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection.","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"R18-20250411","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1681\/ASN.2020081215","article-title":"Exploring the complexity of death-censored kidney allograft failure.","volume":"32","author":"Mayrdorfer","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R19-20250411","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/TP.0000000000003012","article-title":"The causes of kidney allograft failure: more than alloimmunity. A viewpoint article.","volume":"104","author":"Van Loon","year":"2020","journal-title":"Transplantation"},{"key":"R20-20250411","doi-asserted-by":"crossref","first-page":"e14785","DOI":"10.1111\/ctr.14785","article-title":"Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.","volume":"36","author":"Mayer","year":"2022","journal-title":"Clin Transplant"},{"key":"R21-20250411","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1097\/TXD.0000000000001061","article-title":"Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy.","volume":"6","author":"Kant","year":"2020","journal-title":"Transplant Direct"},{"key":"R22-20250411","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1097\/TXD.0000000000001019","article-title":"Donor-derived cell-free DNA in infections in kidney transplant recipients: case series.","volume":"6","author":"Goussous","year":"2020","journal-title":"Transplant Direct"},{"key":"R23-20250411","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ekir.2023.07.011","article-title":"Donor-derived cell-free DNA in biopsy-proven antibody-mediated rejection versus recurrent IgA nephropathy after kidney transplantation.","volume":"8","author":"Akifova","year":"2023","journal-title":"Kidney Int Rep"},{"key":"R24-20250411","doi-asserted-by":"crossref","first-page":"gfad120","DOI":"10.1093\/ndt\/gfad120","article-title":"Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function.","volume":"39","author":"Cucchiari","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R25-20250411","doi-asserted-by":"crossref","first-page":"11899","DOI":"10.3389\/ti.2023.11899","article-title":"Donor-Derived Cell-Free DNA (dd-cfDNA) in kidney transplant recipients with indication biopsy-results of a prospective single-center trial.","volume":"36","author":"Benning","year":"2023","journal-title":"Transpl Int"},{"key":"R26-20250411","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.3389\/ti.2023.12406","article-title":"Donor-derived cell-free DNA: Attractive biomarker seeks a context of use.","volume":"36","author":"Pagliazzi","year":"2023","journal-title":"Transpl Int"},{"key":"R27-20250411","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.3389\/ti.2023.12115","article-title":"European society of organ transplantation consensus statement on testing for non-invasive diagnosis of kidney allograft rejection.","volume":"36","author":"Park","year":"2024","journal-title":"Transpl Int"},{"key":"R28-20250411","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000004339","article-title":"Diagnostic potential of minimally invasive biomarkers: a biopsy-centered viewpoint from the Banff minimally invasive diagnostics working group.","volume":"107","author":"Huang","year":"2023","journal-title":"Transplantation"},{"key":"R29-20250411","doi-asserted-by":"crossref","first-page":"1435578","DOI":"10.3389\/fimmu.2024.1435578","article-title":"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol"},{"key":"R30-20250411","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.kint.2022.09.030","article-title":"A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.","volume":"103","author":"Haas","year":"2023","journal-title":"Kidney Int"},{"key":"R31-20250411","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajt.2023.10.031","article-title":"The Banff 2022 kidney meeting work plan: data-driven refinement of the Banff classification for renal allografts.","volume":"24","author":"Roufosse","year":"2024","journal-title":"Am J Transplant"},{"key":"R32-20250411","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1097\/TXD.0000000000001149","article-title":"Donor-derived cell-free DNA kinetics post-kidney transplant biopsy.","volume":"7","author":"Kyeso","year":"2021","journal-title":"Transplant Direct"},{"key":"R33-20250411","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R34-20250411","doi-asserted-by":"crossref","first-page":"943502","DOI":"10.3389\/fmed.2022.943502","article-title":"The natural history of de novo donor-specific HLA antibodies after kidney transplantation.","volume":"9","author":"L\u00f3pez Del Moral","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R35-20250411","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.14521","article-title":"Determination of unacceptable HLA antigen mismatches in kidney transplant recipients.","volume":"100","author":"Ziemann","year":"2022","journal-title":"HLA"},{"key":"R36-20250411","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 kidney meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"R37-20250411","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2021091191","article-title":"The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies.","volume":"33","author":"Halloran","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R38-20250411","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0000000000004324","article-title":"Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: Results from the trifecta study.","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"R39-20250411","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.trim.2021.101404","article-title":"Donor-derived cell-free DNA: an independent biomarker in kidney transplant patients with antibody-mediated rejection.","volume":"69","author":"Cheng","year":"2021","journal-title":"Transpl Immunol"},{"key":"R40-20250411","doi-asserted-by":"crossref","first-page":"1433918","DOI":"10.3389\/fimmu.2024.1433918","article-title":"Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients.","volume":"15","author":"Kim","year":"2024","journal-title":"Front Immunol"},{"key":"R41-20250411","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant"},{"key":"R42-20250411","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.3389\/ti.2022.10448","article-title":"Donor derived cell free DNA in kidney transplantation: the Circa 2020-2021 update.","volume":"35","author":"Kant","year":"2022","journal-title":"Transpl Int"},{"key":"R43-20250411","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/ajt.16883","article-title":"The negative impact of T cell-mediated rejection on renal allograft survival in the modern era.","volume":"22","author":"Rampersad","year":"2022","journal-title":"Am J Transplant"},{"key":"R44-20250411","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/TP.0000000000001707","article-title":"Diffuse extent of peritubular capillaritis in late antibody-mediated rejection: associations with levels of donor-specific antibodies and chronic allograft injury.","volume":"101","author":"Kozakowski","year":"2017","journal-title":"Transplantation"},{"key":"R45-20250411","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2015.64","article-title":"The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.","volume":"88","author":"Kozakowski","year":"2015","journal-title":"Kidney Int"},{"key":"R46-20250411","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2015.99","article-title":"Peritubular capillaritis in the renal allograft takes center stage.","volume":"88","author":"Racusen","year":"2015","journal-title":"Kidney Int"},{"key":"R47-20250411","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1600-6143.2007.02137.x","article-title":"Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates.","volume":"8","author":"Gibson","year":"2008","journal-title":"Am J Transplant"},{"key":"R48-20250411","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ajt.14908","article-title":"Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy.","volume":"19","author":"Park","year":"2019","journal-title":"Am J Transplant"},{"key":"R49-20250411","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/TP.0b013e318295ee5a","article-title":"A rapid noninvasive assay for the detection of renal transplant injury.","volume":"96","author":"Sigdel","year":"2013","journal-title":"Transplantation"},{"key":"R50-20250411","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3389\/fimmu.2020.01763","article-title":"Urine donor-derived cell-free DNA helps discriminate BK polyomavirus-associated nephropathy in kidney transplant recipients with BK polyomavirus infection.","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"R51-20250411","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/nep.13884","article-title":"A novel urine cell-free DNA preservation solution and its application in kidney transplantation.","volume":"26","author":"Zhou","year":"2021","journal-title":"Nephrology (Carlton)"},{"key":"R52-20250411","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1053\/j.ajkd.2023.07.022","article-title":"Automated urinary chemokine assays for noninvasive detection of kidney transplant rejection: a prospective cohort study.","volume":"83","author":"Van Loon","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"R53-20250411","doi-asserted-by":"crossref","first-page":"e12268","DOI":"10.1002\/jev2.12268","article-title":"Extracellular vesicle-bound DNA in urine is indicative of kidney allograft injury.","volume":"11","author":"Sedej","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"R54-20250411","doi-asserted-by":"crossref","first-page":"928516","DOI":"10.3389\/fmed.2022.928516","article-title":"Urinary CD8+HLA-DR+ T cell abundance non-invasively predicts kidney transplant rejection.","volume":"9","author":"Grothgar","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R55-20250411","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.3389\/ti.2024.13239","article-title":"Perspective for donor-derived cell-free DNA in antibody-mediated rejection after kidney transplantation: defining context of use and clinical implications.","volume":"37","author":"Akifova","year":"2024","journal-title":"Transpl Int"},{"key":"R56-20250411","doi-asserted-by":"crossref","first-page":"gfae282","DOI":"10.1093\/ndt\/gfae282","article-title":"Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.","volume":"2024","author":"Akifova","year":"2024","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T22:00:20Z","timestamp":1744322420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001794","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}